Stay updated on SAGE-217 in Essential Tremor Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 in Essential Tremor Clinical Trial page.

Latest updates to the SAGE-217 in Essential Tremor Clinical Trial page
- Check2 days agoChange DetectedA banner announces NIH’s transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record, replacing the usual study details with an error page.SummaryDifference20%

- Check58 days agoChange DetectedThe page's Revision field updated from v3.6.5 to v3.6.6, indicating a new version of the page. The core study details and content remain unchanged.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page gains sponsor and data-sharing details under Related Info and Study Documents, including Biogen as sponsor and the IPD sharing policy. It also updates the record history and adds related topics/links to the page.SummaryDifference75%

Stay in the know with updates to SAGE-217 in Essential Tremor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 in Essential Tremor Clinical Trial page.